PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsdrug overdose
MeSH D062787 - drug overdose
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D063487:Prescription drug misuse
0 Companies
0 Drugs
Success rate
D062787: 
Drug overdose
D000083682:Opiate overdose
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Rising PharmaceuticalsPolyethylene glycol 3350, Tezacitabine, Sodium chloride, Sodium bicarbonate Peg 3350 Electrolytes  2010-01-28   
Polyethylene glycol 3350, Sodium chloride, Sodium bicarbonate Peg, Potassium Chloride, Bicarbonate,  2010-04-02   
Purdue PharmaNalmefene Nalmefene  2022-02-08   
Hikma PharmaceuticalsNalmefene Revex  1995-04-17   
LundbeckNalmefene Selincro  2013-02-24   
BaxterSodium chloride, Sodium bicarbonate Phoxillum B22k  2015-01-13   
Dextrose, Lactic acid, Sodium chloride, Sodium bicarbonate Prismasol  2006-10-25   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
67%
2/3
Phase 2
50%
1/2
Phase 3
100%
6/6
Approved: 6Overall Success rate: 33%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Purdue Pharma
Baxter
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use